Wednesday, 12 Dec 2018

You are here

Dr. Olga Petryna - Canakinumab in CVD Pts Prevents Acute Gout Attacks

Dr. Petryna reviews Dr. Dan Solomon's EULAR 2018 plenary presentation showing a 50-60% reduction in acute gout amongst CVD patients treated with canakinumab.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Dr. Paul Emery ACR17 - Microarray...

20 Nov 2017

Panel Discussion: Drs. Calabrese,...

22 Oct 2018

The RheumNow Week in Review - 17...

17 Nov 2017

EULAR 2016 Round-Up - Dr. Jack Cush

19 Jun 2016

The RheumNow Week in Review – 31 March...

31 Mar 2017

Paul Emery, MD: biosimilar etanercept...

11 Nov 2015

The Week in Review - 1 April 2016

01 Apr 2016

Dr. Bevra Hahn: Lupus and Physician...

11 Feb 2018

The RheumNow Week in Review –...

18 May 2018

Dr. Arthur Lau: Osteoporosis

23 Oct 2018

Dr. Leonard Calabrese: Shingles and...

09 Nov 2015

Dr. Susan Goodman - Newly Released ACR/...

20 Jun 2017